Dominik A. Barth

867 total citations
36 papers, 600 citations indexed

About

Dominik A. Barth is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Dominik A. Barth has authored 36 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cancer Research, 16 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Dominik A. Barth's work include Cancer-related molecular mechanisms research (11 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Dominik A. Barth is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Dominik A. Barth collaborates with scholars based in Austria, United States and Germany. Dominik A. Barth's co-authors include Martin Pichler, Christiane Klec, Felix Prinz, Armin Gerger, Jakob M. Riedl, Ondřej Slabý, Michael Stotz, Florian Posch, Jaroslav Juráček and George A. Calin and has published in prestigious journals such as Blood, Annals of Oncology and Frontiers in Immunology.

In The Last Decade

Dominik A. Barth

36 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominik A. Barth Austria 15 296 284 222 120 74 36 600
Koichi Saruwatari Japan 12 110 0.4× 333 1.2× 342 1.5× 212 1.8× 66 0.9× 38 694
Kathryn Date United Kingdom 6 133 0.4× 237 0.8× 221 1.0× 39 0.3× 82 1.1× 9 555
Hidenobu Kamohara Japan 11 177 0.6× 216 0.8× 147 0.7× 46 0.4× 75 1.0× 24 467
Mohammad Arafa Egypt 14 128 0.4× 223 0.8× 130 0.6× 50 0.4× 82 1.1× 45 589
Hiroshi Tanabe Japan 15 84 0.3× 119 0.4× 128 0.6× 77 0.6× 42 0.6× 49 541
Xiaowei Dang China 12 123 0.4× 163 0.6× 224 1.0× 165 1.4× 82 1.1× 33 509
Jin Lu Tong China 12 135 0.5× 160 0.6× 240 1.1× 68 0.6× 50 0.7× 17 515
Tomonori Iida Japan 12 113 0.4× 128 0.5× 293 1.3× 104 0.9× 95 1.3× 37 576
Xianghua Yi China 14 91 0.3× 206 0.7× 236 1.1× 257 2.1× 68 0.9× 64 700
Davide Brocco Italy 14 107 0.4× 202 0.7× 302 1.4× 75 0.6× 140 1.9× 30 586

Countries citing papers authored by Dominik A. Barth

Since Specialization
Citations

This map shows the geographic impact of Dominik A. Barth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominik A. Barth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominik A. Barth more than expected).

Fields of papers citing papers by Dominik A. Barth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominik A. Barth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominik A. Barth. The network helps show where Dominik A. Barth may publish in the future.

Co-authorship network of co-authors of Dominik A. Barth

This figure shows the co-authorship network connecting the top 25 collaborators of Dominik A. Barth. A scholar is included among the top collaborators of Dominik A. Barth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominik A. Barth. Dominik A. Barth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moik, Florian, Angelika Terbuch, Dominik A. Barth, et al.. (2025). Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortality. Journal of Thrombosis and Haemostasis. 23(9). 2796–2806. 1 indexed citations
2.
Moik, Florian, Jakob M. Riedl, Dominik A. Barth, et al.. (2024). Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors. JACC CardioOncology. 6(6). 965–975. 4 indexed citations
3.
Juráček, Jaroslav, Karolína Trachtová, Dominik A. Barth, et al.. (2023). Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome. Cancer Genomics & Proteomics. 20(3). 308–316. 5 indexed citations
4.
Pichler, Renate, Peter J. Siska, Piotr Tymoszuk, et al.. (2023). A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma. Frontiers in Immunology. 14. 1095195–1095195. 14 indexed citations
5.
Lindner, Andrea Katharina, Piotr Tymoszuk, Dominik A. Barth, et al.. (2023). Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy. Biology of Sex Differences. 14(1). 38–38. 5 indexed citations
6.
Hutterer, Georg C., Johannes Mischinger, Maximilian Seles, et al.. (2023). Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery. World Journal of Urology. 41(5). 1359–1364. 1 indexed citations
7.
Lindner, Andrea Katharina, Martin Pichler, Hanno Ulmer, et al.. (2023). Optimization of postoperative surveillance protocols in upper tract urothelial cancer: A retrospective cohort study. Frontiers in Oncology. 13. 1143030–1143030. 8 indexed citations
8.
Juráček, Jaroslav, Michal Staník, Karolína Trachtová, et al.. (2022). A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer. The Prostate. 83(4). 340–351. 2 indexed citations
9.
Barth, Dominik A., Stefanie Stanzer, Thomas Bauernhofer, et al.. (2022). Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study. Frontiers in Immunology. 13. 840207–840207. 18 indexed citations
10.
Riedl, Jakob M., Florian Posch, Lena Horvath, et al.. (2021). Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis. European Journal of Cancer. 151. 3–13. 37 indexed citations
11.
Smolle, Maria Anna, Dominik A. Barth, Florian Posch, et al.. (2021). The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma. Anticancer Research. 41(1). 429–436. 19 indexed citations
12.
Müller, Moritz, Florian Posch, Dominik A. Barth, et al.. (2021). Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis. Therapeutic Advances in Medical Oncology. 13. 4277451962–4277451962. 1 indexed citations
13.
Taheri, Mohammad, Dominik A. Barth, Julia Kargl, et al.. (2021). Emerging Role of Non-Coding RNAs in Regulation of T-Lymphocyte Function. Frontiers in Immunology. 12. 756042–756042. 30 indexed citations
14.
Barth, Dominik A., Andrea Katharina Lindner, Georg C. Hutterer, et al.. (2021). Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up. Urologic Oncology Seminars and Original Investigations. 39(10). 736.e9–736.e16. 3 indexed citations
15.
Barth, Dominik A., et al.. (2020). Involvement of Long Non-Coding RNAs (lncRNAs) in Tumor Angiogenesis. Non-Coding RNA. 6(4). 42–42. 42 indexed citations
16.
Hutterer, Georg C., et al.. (2020). MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients. Non-Coding RNA. 6(1). 2–2. 14 indexed citations
17.
Barth, Dominik A., et al.. (2020). Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in Cancer. Non-Coding RNA. 6(3). 27–27. 39 indexed citations
18.
Barth, Dominik A., Rareş Drulă, Leonie Ott, et al.. (2020). Circulating Non-coding RNAs in Renal Cell Carcinoma—Pathogenesis and Potential Implications as Clinical Biomarkers. Frontiers in Cell and Developmental Biology. 8. 828–828. 26 indexed citations
19.
Barth, Dominik A., Julia Riedl, Florian Posch, et al.. (2019). Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study. Clinical & Translational Oncology. 21(8). 1034–1043. 3 indexed citations
20.
Barth, Dominik A., Ondřej Slabý, Christiane Klec, et al.. (2019). Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma. Cancers. 11(10). 1580–1580. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koichi Saruwatari Breakdown of academic impact, for papers by Kathryn Date Breakdown of academic impact, for papers by Hidenobu Kamohara Breakdown of academic impact, for papers by Mohammad Arafa Breakdown of academic impact, for papers by Hiroshi Tanabe Breakdown of academic impact, for papers by Xiaowei Dang Breakdown of academic impact, for papers by Jin Lu Tong Breakdown of academic impact, for papers by Tomonori Iida Breakdown of academic impact, for papers by Xianghua Yi Breakdown of academic impact, for papers by Davide Brocco
Rankless by CCL
2026